As of April 16, 2025, MacroGenics (MGNX) has a market cap of $71.607 million USD. According to our data, MacroGenics is ranked No.7814 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $71.61 M |
-64.90%
|
Dec 31, 2024 | $0.20 B |
-66.22%
|
Dec 29, 2023 | $0.60 B |
43.37%
|
Dec 30, 2022 | $0.42 B |
-58.19%
|
Dec 31, 2021 | $1.01 B |
-29.79%
|
Dec 31, 2020 | $1.43 B |
110.11%
|
Dec 31, 2019 | $0.68 B |
-14.33%
|
Dec 31, 2018 | $0.80 B |
-33.16%
|
Dec 29, 2017 | $1.19 B |
-7.05%
|
Dec 30, 2016 | $1.28 B |
-34.00%
|
Dec 31, 2015 | $1.94 B |
-11.69%
|
Dec 31, 2014 | $2.20 B |
27.85%
|
Dec 31, 2013 | $1.72 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Eli Lilly
LLY
|
$661.83 B |
0.020 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$371.78 B |
-0.011 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$304.44 B |
-0.071 B
|
![]() USA
|
![]() Novo Nordisk
NVO
|
$283.94 B |
69.324 B
|
![]() Denmark
|
![]() Novo Nordisk A/S
NOVO-B.CO
|
$283.01 B |
66.288 B
|
![]() Denmark
|
![]() Roche
ROG.SW
|
$247.80 B |
33.129 B
|
![]() Switzerland
|
![]() Novartis
NVS
|
$218.90 B |
1.166 B
|
![]() Switzerland
|
![]() AstraZeneca
AZN
|
$209.53 B |
-0.000 M
|
![]() UK
|
![]() Merck
MRK
|
$194.39 B |
-0.005 M
|
![]() USA
|
![]() Thermo Fisher Scientific
TMO
|
$166.53 B |
0.003 M
|
![]() USA
|
![]() Amgen
AMGN
|
$153.50 B |
0.127 B
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.93 B |
0.001 M
|
![]() USA
|
![]() Sanofi
SNY
|
$128.36 B |
3.704 B
|
![]() France
|
![]() Pfizer
PFE
|
$126.56 B |
0.001 M
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$126.17 B |
0.004 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$101.21 B |
0.002 M
|
![]() USA
|
![]() CVS Health
CVS
|
$87.39 B |
0.000 M
|
![]() USA
|
![]() Chugai Pharmaceutical
4519.T
|
$77.71 B |
1.323 B
|
![]() Japan
|
![]() CSL
CSL.AX
|
$74.32 B |
-0.679 B
|
![]() Australia
|
![]() GlaxoSmithKline
GSK
|
$72.40 B |
-0.002 M
|
![]() UK
|
Market Cap | = | MGNX Stock Price | * | MGNX Shares Outstanding |
= | $1.13 | * | 63.09 M | |
= | $71.61 M |